BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33704407)

  • 21. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
    Jelinek GA; Marck CH; Weiland TJ; Pereira N; van der Meer DM; Hadgkiss EJ
    BMC Neurol; 2015 Aug; 15():132. PubMed ID: 26243188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitamin D and latitude as environmental factors in multiple sclerosis].
    Niino M; Miyazaki Y; Fukazawa T; Kikuchi S
    Nihon Rinsho; 2014 Nov; 72(11):1924-9. PubMed ID: 25518372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of multiple sclerosis in the world: an update.
    Rosati G
    Neurol Sci; 2001 Apr; 22(2):117-39. PubMed ID: 11603614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental factors in multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):3-9. PubMed ID: 24289836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.
    Kampman MT; Aarseth JH; Grytten N; Benjaminsen E; Celius EG; Dahl OP; Holmøy T; Løken-Amsrud K; Midgard R; Myhr KM; Risberg G; Vatne A; Torkildsen O
    J Neurol; 2013 Jun; 260(6):1481-8. PubMed ID: 23292231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis?
    McMichael AJ; Hall AJ
    Epidemiology; 1997 Nov; 8(6):642-5. PubMed ID: 9345663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latitudinal variation in MS incidence in Scotland.
    McDonald JJ; Weller B; O'Neil M; Waters C; O'Riordan J;
    Mult Scler Relat Disord; 2019 Jul; 32():116-122. PubMed ID: 31112929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation of ultraviolet radiation and multiple sclerosis in Newfoundland.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Can J Neurol Sci; 2008 Mar; 35(1):69-74. PubMed ID: 18380280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.
    Handel AE; Jarvis L; McLaughlin R; Fries A; Ebers GC; Ramagopalan SV
    PLoS One; 2011 Jan; 6(1):e14606. PubMed ID: 21298053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway.
    Kampman MT; Brustad M
    Neuroepidemiology; 2008; 30(3):140-6. PubMed ID: 18382112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate pneumonitis in rheumatoid arthritis: increased prevalence with increasing latitude: an epidemiological study of trends in new zealand.
    Jordan SR; Stevanovic VR; Herbison P; Dockerty J; Highton J
    J Clin Rheumatol; 2011 Oct; 17(7):356-7. PubMed ID: 21946458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory.
    Pugliatti M; Sotgiu S; Solinas G; Castiglia P; Rosati G
    Neurol Sci; 2001 Apr; 22(2):163-5. PubMed ID: 11603620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of multiple sclerosis in the Leeds Health Authority.
    Ford HL; Gerry E; Airey CM; Vail A; Johnson MH; Williams DR
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):605-10. PubMed ID: 9598675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends in multiple sclerosis prevalence and incidence in a large population.
    Rotstein DL; Chen H; Wilton AS; Kwong JC; Marrie RA; Gozdyra P; Krysko KM; Kopp A; Copes R; Tu K
    Neurology; 2018 Apr; 90(16):e1435-e1441. PubMed ID: 29549225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and incidence of multiple sclerosis in Salerno (southern Italy) and its province.
    Iuliano G; Napoletano R
    Eur J Neurol; 2008 Jan; 15(1):73-6. PubMed ID: 18042236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Location and vitamin D synthesis: is the hypothesis validated by geophysical data?
    Kimlin MG; Olds WJ; Moore MR
    J Photochem Photobiol B; 2007 Mar; 86(3):234-9. PubMed ID: 17142054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
    Pierrot-Deseilligny C; Souberbielle JC
    Brain; 2010 Jul; 133(Pt 7):1869-88. PubMed ID: 20584945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for an Association Between Vitamin D and Multiple Sclerosis.
    Pakpoor J; Ramagopalan S
    Curr Top Behav Neurosci; 2015; 26():105-15. PubMed ID: 25502544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disability profile of multiple sclerosis in New Zealand.
    Alla S; Pearson JF; Taylor BV; Miller DH; Clarke G; Richardson A; Willoughby E; Abernethy DA; Sabel CE; Mason DF
    J Clin Neurosci; 2016 Jun; 28():97-101. PubMed ID: 26765754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occurrence of multiple sclerosis in the north and south of New Zealand.
    Skegg DC; Corwin PA; Craven RS; Malloch JA; Pollock M
    J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):134-9. PubMed ID: 3494813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.